Stroke device trial pulled before it even started
NCT ID NCT06386289
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This trial was designed to test a device called the CEREGLIDE 92 catheter, which aims to remove large blood clots from the brain in people having a severe stroke. The study planned to enroll patients with acute ischemic stroke and high disability scores. However, the trial was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CEREGLIDE 92 intermediate catheter
- What this could lead to
- If successful, this device could improve blood flow restoration in stroke patients with a single pass, potentially reducing brain damage and disability.
- What could go wrong
- The trial was withdrawn before enrolling any participants, so no data is available. The device may not work as intended or could cause complications like vessel damage or bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?